PLoS Med:胸部创伤,CT扫描区域可以减小

2015-10-09 赵洲 译 MedSci原创

 在过去的二十年中,CT技术已经越来越多地用于成年人钝性创伤评价诊断,许多创伤中心采用常规的从头到骨盆的CT扫描。许多研究已经表明CT使用的延长和癌症风险有关。目前,许多专业机构已经呼吁对创伤CT诊断进行评价。对于有效的放射剂量,胸部CT的致癌风险相当大。此外,不必要的创伤胸部CT也可能会导致不必要的医疗花费。此前研究表明,在进行X光检查后进行胸部CT是一项低产出的事情,这导致了超过20

在过去的二十年中,CT技术已经越来越多地用于成年人钝性创伤评价诊断,许多创伤中心采用常规的从头到骨盆的CT扫描。许多研究已经表明CT使用的延长和癌症风险有关。目前,许多专业机构已经呼吁对创伤CT诊断进行评价。对于有效的放射剂量,胸部CT的致癌风险相当大。此外,不必要的创伤胸部CT也可能会导致不必要的医疗花费。此前研究表明,在进行X光检查后进行胸部CT是一项低产出的事情,这导致了超过20万美元的浪费并且每23个创伤诊断患者中可能有一个会被诱发癌症。


为了引出和确证钝性创伤诊断中的选择性胸部CT的两种决策仪器(DI),研究人员进行了为期三年的多中心、前瞻性观测试验。受试者都是年龄在14岁以上。在第一阶段,医生记录了在查看胸部成像结果前的14项临床条件存在与否。研究人员通过CT放射学和根据临床分类指标对受伤程度进行分类,从而确定最终的受伤结果。采用两种递归分区导出两种DI:胸部全CT和胸部主要CT。在随后的确证阶段,使用类似的方法对两种方法进行前瞻性检测。不过有的医生认为这项工作仍有局限性,比如创伤分类和检测的敏感度阈值。

通过此项研究,引出并且确证了两种DI,这减少了不必要胸部CT的使用。既节省了患者的医疗花费,又使得患者患癌风险降低,可谓是一举两得。

原始出处:

Rodriguez RM, Langdorf MI, Nishijima D, Baumann BM, Hendey GW, Medak AJ, et al. (2015) Derivation and Validation of Two Decision Instruments for Selective Chest CT in Blunt Trauma:A Multicenter Prospective Observational Study (NEXUS Chest CT). PLoS Med 12(10): e1001883.doi:10.1371/journal.pmed.1001883

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=107760, encodeId=1e7210e7607e, content=这篇咨询不错哦,值得学习,对于临床工作和科研思路都很有帮助。, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzUn81b5CF5ibVPib8jWI92iciaxmqGHlwruOnK4SVZykd4iahqo1hicklIibyZoxm55X7EM8BW9eX1h1hQ2/0, createdBy=8aa81937526, createdName=李东泽, createdTime=Tue Aug 30 23:02:00 CST 2016, time=2016-08-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1335085, encodeId=20d0133508538, content=<a href='/topic/show?id=e7cc32022c7' target=_blank style='color:#2F92EE;'>#创伤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32022, encryptionId=e7cc32022c7, topicName=创伤)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aa5a2500103, createdName=ms920641618706883, createdTime=Sun Oct 11 09:09:00 CST 2015, time=2015-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1606647, encodeId=7885160664e3f, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Sun Oct 11 09:09:00 CST 2015, time=2015-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1618759, encodeId=32ed1618e59ff, content=<a href='/topic/show?id=aa2e5463db' target=_blank style='color:#2F92EE;'>#CT扫描#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5463, encryptionId=aa2e5463db, topicName=CT扫描)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ed3819951332, createdName=ms6323715314570549, createdTime=Sun Oct 11 09:09:00 CST 2015, time=2015-10-11, status=1, ipAttribution=)]
    2016-08-30 李东泽

    这篇咨询不错哦,值得学习,对于临床工作和科研思路都很有帮助。

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=107760, encodeId=1e7210e7607e, content=这篇咨询不错哦,值得学习,对于临床工作和科研思路都很有帮助。, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzUn81b5CF5ibVPib8jWI92iciaxmqGHlwruOnK4SVZykd4iahqo1hicklIibyZoxm55X7EM8BW9eX1h1hQ2/0, createdBy=8aa81937526, createdName=李东泽, createdTime=Tue Aug 30 23:02:00 CST 2016, time=2016-08-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1335085, encodeId=20d0133508538, content=<a href='/topic/show?id=e7cc32022c7' target=_blank style='color:#2F92EE;'>#创伤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32022, encryptionId=e7cc32022c7, topicName=创伤)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aa5a2500103, createdName=ms920641618706883, createdTime=Sun Oct 11 09:09:00 CST 2015, time=2015-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1606647, encodeId=7885160664e3f, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Sun Oct 11 09:09:00 CST 2015, time=2015-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1618759, encodeId=32ed1618e59ff, content=<a href='/topic/show?id=aa2e5463db' target=_blank style='color:#2F92EE;'>#CT扫描#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5463, encryptionId=aa2e5463db, topicName=CT扫描)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ed3819951332, createdName=ms6323715314570549, createdTime=Sun Oct 11 09:09:00 CST 2015, time=2015-10-11, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=107760, encodeId=1e7210e7607e, content=这篇咨询不错哦,值得学习,对于临床工作和科研思路都很有帮助。, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzUn81b5CF5ibVPib8jWI92iciaxmqGHlwruOnK4SVZykd4iahqo1hicklIibyZoxm55X7EM8BW9eX1h1hQ2/0, createdBy=8aa81937526, createdName=李东泽, createdTime=Tue Aug 30 23:02:00 CST 2016, time=2016-08-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1335085, encodeId=20d0133508538, content=<a href='/topic/show?id=e7cc32022c7' target=_blank style='color:#2F92EE;'>#创伤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32022, encryptionId=e7cc32022c7, topicName=创伤)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aa5a2500103, createdName=ms920641618706883, createdTime=Sun Oct 11 09:09:00 CST 2015, time=2015-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1606647, encodeId=7885160664e3f, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Sun Oct 11 09:09:00 CST 2015, time=2015-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1618759, encodeId=32ed1618e59ff, content=<a href='/topic/show?id=aa2e5463db' target=_blank style='color:#2F92EE;'>#CT扫描#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5463, encryptionId=aa2e5463db, topicName=CT扫描)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ed3819951332, createdName=ms6323715314570549, createdTime=Sun Oct 11 09:09:00 CST 2015, time=2015-10-11, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=107760, encodeId=1e7210e7607e, content=这篇咨询不错哦,值得学习,对于临床工作和科研思路都很有帮助。, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzUn81b5CF5ibVPib8jWI92iciaxmqGHlwruOnK4SVZykd4iahqo1hicklIibyZoxm55X7EM8BW9eX1h1hQ2/0, createdBy=8aa81937526, createdName=李东泽, createdTime=Tue Aug 30 23:02:00 CST 2016, time=2016-08-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1335085, encodeId=20d0133508538, content=<a href='/topic/show?id=e7cc32022c7' target=_blank style='color:#2F92EE;'>#创伤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32022, encryptionId=e7cc32022c7, topicName=创伤)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aa5a2500103, createdName=ms920641618706883, createdTime=Sun Oct 11 09:09:00 CST 2015, time=2015-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1606647, encodeId=7885160664e3f, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Sun Oct 11 09:09:00 CST 2015, time=2015-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1618759, encodeId=32ed1618e59ff, content=<a href='/topic/show?id=aa2e5463db' target=_blank style='color:#2F92EE;'>#CT扫描#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5463, encryptionId=aa2e5463db, topicName=CT扫描)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ed3819951332, createdName=ms6323715314570549, createdTime=Sun Oct 11 09:09:00 CST 2015, time=2015-10-11, status=1, ipAttribution=)]

相关资讯

腰椎间盘突出CT和MRI读片技巧

椎间盘突出症是一种多发病,要确诊自己是否患有腰椎间盘突出症,最好的方法是去医院拍一张腰部CT片或者MRI(磁共振片子)。 不过一般医生都没有充裕的时间把片子报告详细解释给你听,患者常常只能拿着“语言简练”的CT或者磁共振报告单对自己的病情似懂非懂。 不要着急~现在就来手把手教你,怎样自己也能看懂CT和MRI磁共振片子,做到自己心中有数。学习本看片教程不需要以前有医学知识背景,只

FDA批准低剂量CT肺癌筛查方案用于高危人群的早期筛查

GE医疗近日宣布,该公司开发的低剂量计算机断层扫描(LDCT)肺癌筛查方案(LCS)获得美国FDA批准,这也是FDA批准用于肺癌高危群体筛查的首个低剂量CT解决方案。此次批准同时也标志着FDA首次批准将CT设备用于疾病的筛查。此前,美国预防服务工作组(USPSTF)和医疗保险及医疗补助服务中心(CMS)已推荐符合条件的人群每年进行低剂量CT筛查,同时低剂量CT应作为常规肺癌筛查项目。此外,美国Me

JCO:又一早期肺癌生物学标志物---diacetylspermine被发现

Science Daily:又一早期肺癌生物标志物的发现尽管几十年以来一直在宣传吸烟的害处,但是肺癌仍是美国第二大常见的癌症,同时也是因癌死亡的最常见病因。通常患者确诊肺癌时,病情已处于晚期,治疗十分困难。来自加州大学戴维斯分校代谢组学中心的研究人员正尝试通过确定肺癌早期的生物学标志物以改变这一状况。早期诊断是肺癌治疗的关键,对高危人群进行定期的低剂量CT扫描可早期诊断肺癌,但是行这些检查所需的费

ERS 2015:CT随访有助于提高肺癌术后患者生存率

2015年欧洲呼吸学会大会在荷兰阿姆斯特丹召开,研究人员提出,如果肺癌复发患者接受后续胸部CT检查,则他们的术后生存率会得到进一步提高。这是第一个展示肺癌患者术后接受CT追踪随访可提高总生存期限的研究,并且有利于肺癌患者的预后,并提高其生存质量。 既往研究已经证实,对肺癌切除术后的患者随访过程中进行CT检查,大多数情况下都可在患者表现复发临床表现之前监测到复发的征兆。这有助于医生尽早确立诊断,采取

临床上CT、MRI、PET三种检查的比较

CT(X线电子计算机断层扫描)主要是利用X线断层扫描,电光子探测器接收,并把信号转化为数字输入电子计算机,再由计算机转化为图像,是一种无痛苦、无损伤的辅助检查工具。CT的特点:具有检查方便、安全、无痛苦、无创伤的特点。图像清晰、分辩力高、解剖关系明确、病态显影清楚。与MRI比较起来,CT的优点主要在于对骨性疾病、早期脑出血的显示优于MRI,同时成像速度快,器官的运动伪影较小,CT的优势还在对肺部、

CT技术术语及常见病名的中英文对照

A----------abscess of kidney 肾脓肿acoustic 听神经瘤acute pancreatitis 急性胰腺炎analog 模拟analog/digital converter 模拟/数字转化器angiography of spinal cord 脊髓血管造影angioma 血管瘤angiomyolipoma 血管平滑肌脂肪瘤anterior cerebral ar